Search Results for "A-200"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for A-200. Results 301 to 310 of 665 total matches.

Fentanyl Buccal Tablet (Fentora) for Breakthrough Pain

   
The Medical Letter on Drugs and Therapeutics • Sep 24, 2007  (Issue 1270)
from 600-800 mcg of the transmucosal lozenge can start with 200 mcg; a conversion table is included ...
The FDA has approved a transmucosal tablet formulation of fentanyl citrate (Fentora - Cephalon) for management of breakthrough pain in opioid-tolerant patients with cancer. An oral transmucosal fentanyl lozenge on a stick (Actiq, and others) is also available for this indication, and is widely used off-label for chronic, non-cancer pain as well.
Med Lett Drugs Ther. 2007 Sep 24;49(1270):79-6 |  Show IntroductionHide Introduction

Expanded Table: Some Available Insulins for Type 2 Diabetes (online only)

   
The Medical Letter on Drugs and Therapeutics • May 06, 2019  (Issue 1571)
insulin pens are available in boxes containing 5 pens each. Humalog 200 units/mL, Humulin R 500 units/mL ...
View the Expanded Table: Some Available Insulins
Med Lett Drugs Ther. 2019 May 6;61(1571):e73-7 |  Show IntroductionHide Introduction

Estradiol/Progesterone (Bijuva) for Menopausal Vasomotor Symptoms

   
The Medical Letter on Drugs and Therapeutics • Jul 01, 2019  (Issue 1575)
7.3016 Oral Progestogens Progesterone (micronized) – generic 100, 200 mg caps 100 mg PO once/day17 ...
The FDA has approved Bijuva (TherapeuticsMD), a fixed-dose combination of estradiol and progesterone, for oral treatment of moderate to severe vasomotor symptoms (hot flashes) due to menopause in women with an intact uterus. The manufacturer is marketing Bijuva as "the first and only FDA-approved combination of bio-identical estradiol and bio-identical progesterone in a single daily oral capsule".
Med Lett Drugs Ther. 2019 Jul 1;61(1575):99-101 |  Show IntroductionHide Introduction

Drugs for Migraine

   
The Medical Letter on Drugs and Therapeutics • Jun 12, 2023  (Issue 1678)
tabs 50 or 100 mg PO; can be repeated 1.40/73.509 Imitrex (GSK) after 2 hrs (max 200 mg/day) 6 mg/0.5 ...
An oral nonopioid analgesic is often sufficient for acute treatment of mild to moderate migraine pain without severe nausea or vomiting. A triptan is the drug of choice for treatment of moderate to severe migraine in most patients without vascular disease. Treatment of pain when it is still mild to moderate in intensity improves headache response and reduces the risk of recurrence.
Med Lett Drugs Ther. 2023 Jun 12;65(1678):89-96   doi:10.58347/tml.2023.1678a |  Show IntroductionHide Introduction

Pioglitazone (Actos)

   
The Medical Letter on Drugs and Therapeutics • Nov 19, 1999  (Issue 1066)
dosage Cost 1 Troglitazone − Rezulin (Parke-Davis) 200 to 600 mg once 2 89.28 Rosiglitazone ...
Pioglitazone is the third thiazolidinedione ("glitazone") to be marketed in the USA for treatment of type 2 diabetes. Thiazolidinediones decrease resistance to insulin.
Med Lett Drugs Ther. 1999 Nov 19;41(1066):112 |  Show IntroductionHide Introduction

Treatment of COVID-19 in High-Risk Outpatients (online only)

   
The Medical Letter on Drugs and Therapeutics • Jan 28, 2022  (Issue 1643)
(Veklury) • Dosage: 200 mg IV day 1, then 100 mg IV days 2 and 35 • Begin ≤7 days after symptom onset ...
View the Treatment of COVID-19 in High-Risk Outpatients Chart
Med Lett Drugs Ther. 2022 Jan 28;64(1643):e1 |  Show IntroductionHide Introduction

Comparison Chart: Interleukin (IL) Receptor Antagonists for Atopic Dermatitis (online only)

   
The Medical Letter on Drugs and Therapeutics • Feb 17, 2025  (Issue 1722)
– Dupixent (Sanofi/Regeneron) 200 mg/1.14 mL, 300 mg/2 mL prefilled pens, syringes IL-4 and IL-13 inhibitor ...
View the Comparison Chart: Interleukin (IL) Receptor Antagonists for Atopic Dermatitis
Med Lett Drugs Ther. 2025 Feb 17;67(1722):e1   doi:10.58347/tml.2025.1722f |  Show IntroductionHide Introduction

A New Ace Inhibitor and Two New Angiotensin Receptor Blockers For Hypertension

   
The Medical Letter on Drugs and Therapeutics • Nov 05, 1999  (Issue 1065)
in about 200 patients with mild-to-moderate hypertension not well controlled by hydrochlorothiazide ...
Perindopril, the tenth angiotensin converting enzyme (ACE) inhibitor to be marketed in the USA, and telmisartan and eprosartan, the fifth and sixth angiotensin receptor blockers, have recently become available for treatment of hypertension.
Med Lett Drugs Ther. 1999 Nov 5;41(1065):105-6 |  Show IntroductionHide Introduction

Beta-blockers For Heart Failure

   
The Medical Letter on Drugs and Therapeutics • Jun 26, 2000  (Issue 1081)
2 − Toprol XL (AstraZeneca) 12.5 to 25 mg once/day 200 mg once/day 49.13 1. Cost to the patient ...
Standard treatment for patients with heart failure has included a diuretic, digitalis and an ACE inhibitor. In recent years carvedilol, a nonselective beta-blocker with alpha-1 blocking activity, and the beta-selective blockers bisoprolol and metroprolol have also been used for this indication.
Med Lett Drugs Ther. 2000 Jun 26;42(1081):54-5 |  Show IntroductionHide Introduction

Darbepoetin (Aranesp) - A long-acting Erythropoietin

   
The Medical Letter on Drugs and Therapeutics • Dec 10, 2001  (Issue 1120)
. DOSAGE AND COST — Darbepoetin is available in single-dose vials of 25, 40, 60, 100 and 200 mcg ...
Darbepoetin alfa (Aranesp) has been approved by the FDA for treatment of anemia caused by chronic renal disease and will probably also be approved for use in patients with cancer..
Med Lett Drugs Ther. 2001 Dec 10;43(1120):109-10 |  Show IntroductionHide Introduction